Search Filters
Advanced Search
SMC ID Date Medicine Submission Type Indication
1031/15 13/04/2015 regorafenib (Stivarga) Full Treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) who progressed on or are intolerant to prior treatment with imatinib and sunitinib.
855/13 11/11/2013 axitinib (Inlyta) Resubmission For the treatment of adult patients with advanced renal cell carcinoma (RCC) after failure of prior treatment with sunitinib or a cytokine.
698/11 09/05/2011 sunitinib (Sutent) Full Treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults.
275/06 09/11/2009 sunitinib (Sutent) Resubmission Unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST) after failure of imatinib mesylate treatment due to resistance or intolerance.
384/07 09/07/2007 sunitinib 12.5mg, 25mg, 50mg capsules (Sutent) Full First line treatment of advanced and/or metastatic renal cell carcinoma (MRCC)
343/07 12/02/2007 sunitinib 50mg capsule (Sutent) Full Advanced and/or metastatic renal cell carcinoma
275/06 09/10/2006 sunitinib 50mg capsule (Sutent) Full Unresectable and/or metastatic malignant gastrointestinal stromal tumour

No medicines have been found.